Intracranial Aneurysm
Conditions
Keywords
intracranial aneurysm, online registration platform, artificial intelligence, multidimensional model
Brief summary
In this study, 20 regional neurosurgery centers across the country will be included, and the study cohort will be constructed on the basis of the IARP-CP cohort.The artificial intelligence platform was used to analyze the clinical, morphological, hemodynamics, aneurysm wall characteristics and other factors of unruptured aneurysms, as well as the relationship between these factors and the risk of aneurysm instability, seek the potential risk factors, and finally establish a multi-dimensional prediction model of rupture risk of intracranial aneurysms.
Interventions
OTHERObervation
This study is an observational study without any intervention
Sponsors
Beijing Hospital
Peking University Third Hospital
Beijing Sanbo Brain Hospital
Beijing Chao Yang Hospital
Binzhou Renmin Hospital
Fujian Medical University Union Hospital
First Affiliated Hospital of Fujian Medical University
Guangzhou Red Cross Hospital
The First Affiliated Hospital of Haerbin Medical University
The Affiliated Hospital of Qingdao University
Shanxi Provincial People's Hospital
Beijing Tsinghua Changgeng Hospital
RenJi Hospital
Sichuan Provincial People's Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
The Affiliated Hospital of Kunming Medical University
Beijing Unimed Technology Company
Beijing Tiantan Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Inclusion criteria
1. 18-75 years old; 2. At least one unruptured intracranial aneurysm was found by CTA; 3. No relevant symptoms, receiving non-operative and conservative observation treatment; 4. Signing the informed consent.
Exclusion criteria
1. Other cerebrovascular structural lesions (such as cerebrovascular malformation and arteriovenous fistula) or craniocerebral tumors; 2. Fusiform or dissecting aneurysms; 3. Traumatic, mycotic and atrial myxoma associated aneurysms; 4. Suffering from systemic connective tissue diseases, such as polycystic kidney disease; 5. Expectant survival of no more than 3 years due to other diseases or poor general conditions; 6. Patients refuse to follow up or cannot communicate with them due to mental diseases; 7. Pregnant women or participating in other aneurysm related studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aneurysm rupture | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Aneurysm growth | 2 years |
Countries
China
Outcome results
None listed